BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18191073)

  • 21. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
    Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
    Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
    Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
    Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
    Halimi JM; Bonnet F; Lange C; Balkau B; Tichet J; Marre M;
    J Hypertens; 2008 Nov; 26(11):2198-206. PubMed ID: 18854761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of cutaneous manifestations in young patients with type 1 diabetes.
    Pavlović MD; Milenković T; Dinić M; Misović M; Daković D; Todorović S; Daković Z; Zecevi RD; Doder R
    Diabetes Care; 2007 Aug; 30(8):1964-7. PubMed ID: 17519431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
    Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
    Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.
    Gupta R; Gupta VP; Bhagat N; Rastogi P; Sarna M; Prakash H; Deedwania PC
    Indian Heart J; 2008; 60(1):26-33. PubMed ID: 19212018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine in metabolic syndrome.
    Guldiken B; Guldiken S; Taskiran B; Koc G; Turgut N; Kabayel L; Tugrul A
    Neurologist; 2009 Mar; 15(2):55-8. PubMed ID: 19276782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke presentation in Type 2 diabetes and the metabolic syndrome.
    Shah IM; Ghosh SK; Collier A
    Diabetes Res Clin Pract; 2008 Jan; 79(1):e1-4. PubMed ID: 17707541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep and the metabolic syndrome.
    Wolk R; Somers VK
    Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus.
    Stephens JW; Hurel SJ; Lowe GD; Rumley A; Humphries SE
    Mol Genet Metab; 2007 Apr; 90(4):422-8. PubMed ID: 17123852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk factors predicting the development of distal symmetrical polyneuropathy in people with type 1 diabetes: A 9-year follow-up study.
    Sibal L; Law HN; Gebbie J; Home P
    Ann N Y Acad Sci; 2006 Nov; 1084():304-18. PubMed ID: 17151310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.